Bioinformatics analysis revealed that many different types of tumor tissues expressed LAIR1 at higher levels than those in their corresponding normal tissues, particularly in acute myeloid leukemia, esophageal cancer, brain tumor, renal clear cell carcinoma and thymoma (Fig. S1A). This evidence concerns the gene LAIR1 and acute myeloid leukemia.